Your Mounjaro price guide · October 2026

SGLT2 and GLP-1 Combination: What UK Patients Should Know (October 2026)

Taking an SGLT2 inhibitor and a GLP-1 medicine together is a decision for your prescriber or diabetes team, not something to start, stop or adjust yourself. They are different classes of medicine. Mounjaro (tirzepatide) is not an SGLT2 inhibitor: it activates the GIP and GLP-1 receptors.1 Current as of October 2026.

£129.99/ 4 weeks
2.5 mg starting dose
One pen. Four weekly doses.

New customers£40 off your first order with code FIRST40. Standard price £169.99.

A woman enjoying a peaceful moment outdoors
UK pharmacy. Personal care.
Support at every step.

From your first consultation to ongoing care.

  • GPhC-registered UK pharmacy
  • Prescriber assessment
  • Temperature-controlled delivery
  • Advice from our pharmacy team

Why this question comes up

People with type 2 diabetes are often prescribed more than one medicine, so it is natural to ask how an SGLT2 inhibitor and a GLP-1 medicine relate.

  • Price includes prescriber assessment and standard delivery — no consultation fees
  • Orders approved by 3pm for next-day tracked delivery
  • GPhC-registered pharmacy 9012878
  • Needles and sharps disposal included

Compare UK Mounjaro Prices

Prices checked 10 October 2026

Published UK provider Mounjaro prices for the 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mg doses, checked 10 October 2026.
Provider2.5mg5mg7.5mg10mg12.5mg15mgNotes
£40 off first order£129.99First orderReorders £144.99£178.99First orderReorders £193.99£239.99First orderReorders £254.99£250.99First orderReorders £265.99£279.99First orderReorders £294.99£289.99First orderReorders £304.99Consultation and next-day tracked delivery included
Boots Online Doctor£179.00£199.00£259.00£299.00£319.00£339.00Free click & collect; cold-chain home delivery chargeable
Asda Online Doctor£148.97£188.97£248.97£278.97£287.47£298.97Refrigerated delivery from £4.50; free click & collect
MedExpress£179.99£189.99£249.99£279.99£299.99£309.99Delivery £2.90 to £3.95; new-customer discount at checkout
Simple Online Pharmacy£169.00£199.99£259.99£279.99£299.99£319.99Delivery £4.99 per order
Oxford Online Pharmacy£143.96£188.96£248.96£278.96£288.96£309.95Free consultation; cold delivery £5.49
Chemist4U£148.00£188.00£248.00£278.00£288.00£298.00Consultation included; free temperature-controlled delivery
Chemist Click£163.99£173.99£232.99£259.99£279.99£299.49Cold-chain delivery charged; £20 off with code
Click Pharmacy£169.99£189.99£239.99£269.99£289.99£299.99Free assessment; delivery £3.50 to £7.95
Medino£147.99£169.99£249.99£269.99£299.99£319.99Consultation and delivery included

Prices collected weekly from each provider's published price list.

A quick overview

What to know
before you start.

  • An SGLT2 inhibitor and a GLP-1 medicine are different classes; whether to combine them is your prescriber's call, based on your full history.
  • Mounjaro is not an SGLT2 inhibitor. Tirzepatide activates both GIP and GLP-1 receptors.
  • We do not supply SGLT2 inhibitors, so ask your GP, diabetes nurse or pharmacist about combining them.
  • Tell any prescriber about every medicine you take, including diabetes tablets, insulin and supplements.
  • Trial results quoted here are for tirzepatide alone with diet and exercise, never for a combination.
In this guide

01 · The core answer

Can you be on both an SGLT2 inhibitor and a GLP-1 medicine?

It can be possible, but whether it is right for you is a clinical decision made by a prescriber who knows your diabetes, kidney function, current medicines and history. Your own situation is what counts.

The two classes are not interchangeable. A GLP-1 medicine works on gut-hormone receptors. An SGLT2 inhibitor belongs to a different group of medicines, with its own patient leaflet, its own side effects and its own monitoring. Reading both leaflets side by side is a sensible first step before any appointment.

If you already take an SGLT2 inhibitor such as dapagliflozin and are thinking about adding a weekly injection, do not change anything on your own. Raise it with the clinician who prescribed the tablet, or with the prescriber reviewing your consultation. Our team reviews your full medicines list as part of the consultation.

02 · At a glance

How the medicines compare

MedicineTypeHow it is givenWhat is known
Mounjaro (tirzepatide)Dual GIP and GLP-1 receptor activatorOnce-weekly pen in six strengths, 2.5mg to 15mgLicensed in the UK for weight management in adults and for type 2 diabetes1
Wegovy (semaglutide)GLP-1 receptor agonistOnce-weekly pen: 0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg2.4mg is the licensed maintenance dose for weight management
Liraglutide (Saxenda and similar)GLP-1 receptor agonistDaily injection, 6mg/mlDaily, unlike the weekly pens
SGLT2 inhibitors (for example dapagliflozin)A different class from GLP-1 medicinesSee the product's own patient leafletNot supplied by us; ask your GP, diabetes nurse or the leaflet

Mounjaro is a GLP-1 and GIP medicine. It is not an SGLT2 inhibitor, and it does not replace one. If you are curious how the two groups compare in general terms, our guide to a GLP-1 agonist versus an SGLT2 inhibitor sets out the differences, and the page on SGLT2 and Mounjaro covers the tirzepatide side.

03 · Your next step

What to do next

If you are a private patient wanting treatment for weight management, start with a free online consultation. Be completely open about any diabetes medicines, including SGLT2 inhibitors, because they affect what the prescriber considers safe. Our weight loss clinic explains the options, and the Mounjaro pen page has more about the treatment.

If you are managing diabetes through the NHS, your diabetes team stays in charge of your diabetes medicines. Do not stop an existing tablet because you have read something online, and do not start a new injection without telling them.

Related guide: Dpp4 and glp 1 combination.

04 · How Mounjaro works

How Mounjaro works, and why it is not an SGLT2 inhibitor

Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1.1 Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin. In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet.

That dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy and Ozempic). It is also why the question "Is Mounjaro an SGLT2 inhibitor?" has a clear answer: no. Tirzepatide works through gut-hormone receptors. An SGLT2 inhibitor is a separate class with its own leaflet.

Mounjaro comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg. It is taken once a week. Keep pens in a fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge at a temperature not above 30°C for up to 30 days after first use, and must then be thrown away.13

Because the two classes act differently, reading about one does not tell you how the other behaves. Keep that in mind when you see pages that blur them together. If you want the wider picture of how GLP-1 treatments relate to other diabetes medicines, our page on GLP-1 and SGLT2 medicines is a good companion read.

05 · What trials show

What the weight-loss evidence does and does not cover

The headline tirzepatide trial is SURMOUNT-1, and it tested tirzepatide alone alongside diet and exercise. It did not test tirzepatide combined with an SGLT2 inhibitor, so it cannot tell you what a combination would do.

In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.2 These are trial averages. Individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them.

At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.2

For a worked example only: for someone starting at 100 kg, 20.9% is about 21 kg. Trial averages do not predict your own result.

06 · Dapagliflozin questions

Dapagliflozin questions

Can dapagliflozin be used with a GLP-1 medicine? That is a prescriber's decision. The dapagliflozin patient leaflet lists medicines to tell your clinician about, and your GP or diabetes nurse can check your particular combination. Our reviewing prescriber will also ask about it during a consultation.

What should I avoid while taking dapagliflozin? The patient information leaflet that came with your supply is the authoritative list. Read the section on what to tell your doctor before taking it, and the section on possible side effects.

Does it reduce appetite or cause rapid weight loss? If you notice rapid or unexpected weight change on any medicine, speak to your prescriber or pharmacist.

How long can you stay on it? Duration is set by the clinician who prescribes it and reviews you. Never stop a long-term diabetes medicine on your own.

Ozempic or dapagliflozin? These are different classes with different jobs, and the choice belongs to you and your diabetes team. If you suspect a side effect from any medicine, you can report it through the Yellow Card scheme.19

07 · Licence and NHS access

Licence, NHS access and who Mounjaro is for

In the UK, Mounjaro is licensed for weight management in adults and for type 2 diabetes.1 NICE has separate guidance for each use: one covering overweight and obesity, and one covering type 2 diabetes.48

Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).46 Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If you have type 2 diabetes and are already on NHS care, your diabetes team decides what is added to your regimen. Private treatment through us is an alternative route, not a replacement for that relationship, and you should keep your team informed.

Other combinations raise similar questions. Our page on insulin with GLP-1 medicines explains the points that apply there.

08 · Preparing for a consultation

How to prepare when you take other medicines

If you take an SGLT2 inhibitor or any other diabetes medicine, a little preparation makes the consultation faster and safer. A prescriber can only judge suitability on what you tell them.

  • Write down every medicine by name, including tablets, injections, insulin, creams and supplements.
  • Note who prescribes each one and when it was last reviewed.
  • Have your most recent diabetes review details to hand, if you have them.
  • List any conditions, past reactions or allergies.
  • Say whether you are pregnant, planning a pregnancy or breastfeeding. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly.
  • Bring your questions about combining medicines, in writing, so you do not forget them.

Our consultation is free, with no obligation. It is reviewed by a GPhC-registered prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

Repeat orders re-check suitability, so if your medicines change, for example when a new tablet is started, tell us before you reorder. We do not auto-ship.

09 · Safety and reporting

Safety, side effects and reporting

Any new symptom after starting or combining medicines deserves a conversation with your prescriber. Do not wait to see whether it passes if it worries you.

You can report suspected side effects from any medicine, including Mounjaro and SGLT2 inhibitors, through the MHRA Yellow Card scheme.19 Reports help regulators spot patterns, and anyone can make one.

Buy only from a registered pharmacy. Anyone offering to supply a prescription medicine without a consultation or prescription is a warning sign, and counterfeit medicine alerts are published by the MHRA.7 You can check our registration, GPhC 9012878, on the GPhC register.12

Mounjaro is a prescription-only medicine, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary. This page is information, not a substitute for medical advice.

10 · Serious side effects

Serious side effects: when to get help straight away

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion) — your prescriber may need to adjust those medicines.1

11 · How ordering works

How ordering works with us

If you decide a Mounjaro pen is worth discussing, the process is straightforward and the consultation comes first.

  • Free online consultation. A short health questionnaire, with no charge and no obligation.
  • Prescriber review. A GPhC-registered prescriber reviews your answers. If treatment is unsuitable, the order is refunded automatically.
  • Dispensing and delivery. Our registered pharmacy dispenses, with same-day dispatch when ordered by 3pm, then free next-day tracked delivery in temperature-controlled packaging. Saturday delivery is £14.99.

Mounjaro comes through official LillyDirect supply, direct from Eli Lilly's UK distribution, as genuine KwikPens. Needles, a sharps bin and injection guidance are included with every order, and ongoing monthly reviews are part of the service.

The free GLPTrackr companion app can help you keep a record of doses and symptoms, which is useful to share at reviews.

How ordering works

How ordering works at EverydayMeds

Three steps, with our pharmacy team alongside you.

  1. EverydayMeds online consultation on a mobile phone

    Step 1: Online consultation — 5–10 minutes

    Complete a confidential health questionnaire covering BMI, medical history and current medication. No payment is taken until you're approved.

  2. A clinician ready to review an online consultation

    Step 2: Prescriber review — usually same day

    A UK registered prescriber checks your suitability against the licensed criteria (BMI ≥30, or ≥27 with a weight-related condition) and contraindications, and confirms your starting dose.

  3. An EverydayMeds delivery box

    Step 3: Next-day tracked delivery

    Dispensed by our GPhC-registered pharmacy in temperature-controlled packaging with needles and a sharps bin included. Orders approved by 3pm for next-day tracked delivery.

Start your free consultation

Prescription and dispatch follow clinical approval. Confirm current delivery options when ordering.

Afterwards you're not on your own: dose-change reviews are built in before each step up, our pharmacist team is available for side-effect questions, and repeat orders re-check suitability rather than auto-shipping.

Your questions, answered

Mounjaro price UK — frequently asked questions

Answers to common questions about Mounjaro prices, NHS access and ongoing treatment.

Ask our pharmacy team
Can you be on both SGLT2 and GLP-1?
Possibly, but it is a decision for the prescriber or diabetes team who knows your history, kidney function and other medicines. They are different classes of medicine. Do not start, stop or change either one yourself. Tell any prescriber about every medicine you take, and read both patient leaflets before your appointment.
Is Mounjaro a SGLT2i?
No. Mounjaro (tirzepatide) is not an SGLT2 inhibitor. It activates two natural gut-hormone receptors, GIP and GLP-1, which help regulate appetite, slow stomach emptying and improve the body's response to insulin. An SGLT2 inhibitor is a separate class of medicine with its own leaflet.
Can dapagliflozin be used with a GLP-1 medicine?
That is a clinical decision for your prescriber or diabetes team, based on your health and current medicines. Check its patient information leaflet, speak to your GP, diabetes nurse or pharmacist, and never change a long-term medicine without advice.
Which is better, Ozempic or dapagliflozin?
Neither is better in general, because they are different classes with different roles. Ozempic is semaglutide licensed for type 2 diabetes — it is not a UK weight-loss medicine, and prescribing it privately for weight loss is off-label. The right choice depends on your diagnosis, other conditions and goals, and belongs with your prescriber.
What to avoid while taking dapagliflozin?
The authoritative list is in the patient information leaflet supplied with your medicine, in the sections on what to tell your doctor beforehand and on side effects. Your pharmacist or diabetes team can answer specific questions.
Does dapagliflozin cause rapid weight loss or reduce appetite?
Check its leaflet. If you notice rapid or unexpected weight change, or any new symptom, speak to your prescriber promptly, and you can report suspected side effects through the Yellow Card scheme.
Can I get Mounjaro if I already take an SGLT2 inhibitor?
You can start a free online consultation and list every medicine you take, including your SGLT2 inhibitor. A GPhC-registered prescriber reviews it and decides whether treatment is suitable. If it is not, your order is refunded automatically. Keep your diabetes team informed throughout.
Mahommed Zunaid Ayub Patel, Superintendent Pharmacist at EverydayMeds

Clinically reviewed by

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist

Accountable for the safe running of our registered pharmacy — from dispensing checks to delivery.

GPhC registration no. 2217101 · check the GPhC register

Reviewed
Last updated
Next review

EverydayMeds is operated by OVIO Ltd · GPhC-registered pharmacy 9012878 · Registered premises, Leicester · Superintendent Pharmacist: Mahommed Zunaid Ayub Patel